Mars celebrates Halfway to Halloween by rolling out new seasonal treats for 2026
Featuring new SKITTLES POP’d Creepy Crunch and TWIX Skulls, the Mars lineup taps into consumer demand for innovative textures and festive shapes.
Featuring new SKITTLES POP’d Creepy Crunch and TWIX Skulls, the Mars lineup taps into consumer demand for innovative textures and festive shapes.
The reformulated Chips & Chunks features 33% more total chocolate vs. the original recipe; the kind of upgrade only the Keebler Elves could deliver.
The conference brought together pharmacists and health care professionals from across the United States and Canada to build momentum for a growing movement focused on safe staffing, patient care, workplace standards and collective power.
Molson Canadian brings “Cheer Canadian” to Buffalo, celebrating fans who united for the Canadian anthem.
Glycerol Phenylbutyrate Oral Liquid, 1.1 grams per mL, is bioequivalent to the reference listed drug (RLD), Ravicti® Oral Liquid, 1.1 grams per mL, of Horizon Therapeutics U.S. Holding LLC.
Aetna Better Health of Louisiana, part of CVS Health, is teaming up with Goodr to launch a mobile food market and nutrition education program to tackle food insecurity and improve chronic disease outcomes statewide.
The falsies created a look that felt both soft and dramatically refined.
America's No. 1 cat food brand puts a stamp of approval on bold behavior, playful chaos and the people who embrace it.
New Chapter brings three targeted formulas for joint comfort, skin health and beauty nourishment to Erewhon.
Retired four-star general and former CIA Director to deliver strategic leadership insights at the industry's premier health, wellness, and consumer goods event.
Science-backed microbiome supplements resM™ and resG prebeet debut on shelves nationwide, bringing Gut-X Axis innovation to millions of consumers.
New changes expected to deliver significant client savings while maintaining rigorous clinical standards.
These results reinforce the roles of IL-4 and IL-13, two of the key and central drivers of type 2 inflammation, in EoE.
“In line with the 2026 theme, 'Costume Art,' the nails were created as an extension of Venus Williams’ dress."
Announcements from both are in line with a federal push for US-produced drugs.
In LUCENT-3, more than 60% of patients who achieved disease clearance at one year maintained it after four years of continuous Omvoh treatment.